ArticleCancers2024

Prognostic Value of Blood-Based Inflammatory Markers in Cancer Patients Receiving Immune Checkpoint Inhibitors.

Mustafa Murat Midik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.